Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.79%
Variazione Mensile
+0.63%
Variazione di 6 mesi
+4.40%
Variazione Annuale
+21.67%
Chiusura Precedente
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Volume
3
Mercati
Mercato Azionario Statunitense
Salute
ICCC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
7.22 M
7.74 M
7.75 M
7.75 M
8.98 M
—
Valuation ratios
Enterprise value
36.01 M
51.76 M
44.41 M
60.1 M
46.01 M
204.41 M
Price to earnings ratio
42.5
-800.01
-20.25
-6.67
-19.81
-86.37
Price to sales ratio
2.8
3.16
2.7
2.22
1.59
7.13
Price to cash flow ratio
32.62
63.66
-32.51
-8.29
117.52
199.16
Price to book ratio
1.52
1.86
1.65
1.55
1.53
2.9
Enterprise value to EBITDA ratio
37.25
19.04
1 125.28
-19.98
42.22
83.53
Profitability ratios
Return on assets %
0.03
-0
-0.06
-0.13
-0.05
0.05
Return on equity %
0.04
-0
-0.08
-0.23
-0.08
0.08
Return on invested capital %
18.3
3.66
-26.46
-59.17
-15.87
21.66
Gross margin %
44.73
44.98
41.19
22.15
29.97
164.75
Operating margin %
9
1.34
-12.38
-32.9
-6.19
31.07
EBITDA margin %
6.3
14.13
0.21
-17.22
4.11
72.01
Net margin %
6.66
-0.41
-13.43
-33.05
-8.14
29.82
Liquidity ratios
Quick ratio
4.55
5.2
2.59
0.92
1.8
7.76
Current ratio
5.5
6.42
4.56
2.78
3.41
15.59
Inventory turnover
3.68
4.09
2.39
1.96
2.49
—
Asset turnover
0.39
0.45
0.42
0.39
0.6
0.61
Solvency ratios
Debt to assets ratio
—
—
—
0.51
—
—
Debt to equity ratio
—
—
—
0.89
—
—
Long term debt to total assets ratio
0.22
0.19
0.2
0.27
0.23
0.81
Long term debt to total equity ratio
0.31
0.26
0.3
0.48
0.38
1.28
Per share metrics
Operating cash flow per share
0.18
0.13
-0.2
-0.6
0.04
0.22
EBIT per share
-0.19
0.03
-0.32
-0.74
-0.2
0.27
EBITDA per share
0.13
0.36
0.01
-0.39
0.13
0.58
Total debt per share
—
—
—
2.88
—
—
Cash per share
1.1
1.34
0.75
0.13
0.03
0.52
Net current asset value per share
1.69
2.14
1.81
1.51
1.84
7.37
Tangible book value per share
3.89
4.27
3.9
3.21
3.36
13.15
Working capital per share
1.38
1.81
1.41
0.97
1.3
5.47
Book value per share
3.92
4.29
3.92
3.23
3.37
13.2
Notizie
I direttori di ImmuCell si dimetteranno all’assemblea annuale 2026
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell annuncia nuovi accordi di lavoro dirigenziali e concessioni di opzioni
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
Trascrizione della relazione sugli utili: ImmuCell Q4 2025 registra movimento positivo delle azioni
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell riporta vendite di $7,6 milioni nel Q4, sposta focus su First Defense
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio